Peptides Becoming Legal in 2026: The PCAC July 23-24 Meeting Explained
On July 23 and 24, 2026, the FDA’s Pharmacy Compounding Advisory Committee will vote on seven peptides that biohackers, longevity clinics, and a few hundred thousand patients have been buying through the gray market for years. BPC-157 is on the docket. So are TB-500, KPV, MOTs-C, Semax, Epitalon, and DSIP. A second meeting before the …